Literature DB >> 15193758

Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats.

Christophe Jollivet1, Claudia N Montero-Menei, Marie-Claire Venier-Julienne, Anne Sapin, Jean-Pierre Benoit, Philippe Menei.   

Abstract

Only a few studies mention the existence of tyrosine hydroxylase immunoreactive neurons in the striatum. These neurons are known to be increased following lesion of the dopaminergic nigrostriatal pathway. Recently it has been shown that glial cell line-derived neurotrophic factor treatment was able to increase the number of these neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated primate. Here we report that, in the rat, these neurons are responsive to intrastriatal injection of 6-hydroxydopamine and that following the lesion their number tends to increase with time. Moreover, we have shown that L-DOPA treatment for 2 weeks or nerve growth factor treatment for 8 weeks are able to dramatically augment their number. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193758     DOI: 10.1016/j.neulet.2004.02.068

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway.

Authors:  Bengi Ünal; Fulva Shah; Janish Kothari; James M Tepper
Journal:  Brain Struct Funct       Date:  2013-10-31       Impact factor: 3.270

2.  Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3a(EGFP) Mouse.

Authors:  A B Muñoz-Manchado; C Foldi; S Szydlowski; L Sjulson; M Farries; C Wilson; G Silberberg; J Hjerling-Leffler
Journal:  Cereb Cortex       Date:  2014-08-21       Impact factor: 5.357

3.  Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.

Authors:  Nabil El Massri; Ana P Lemgruber; Isobel J Rowe; Cécile Moro; Napoleon Torres; Florian Reinhart; Claude Chabrol; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

4.  Heterogeneity and diversity of striatal GABAergic interneurons.

Authors:  James M Tepper; Fatuel Tecuapetla; Tibor Koós; Osvaldo Ibáñez-Sandoval
Journal:  Front Neuroanat       Date:  2010-12-29       Impact factor: 3.856

5.  High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers.

Authors:  Carla L Busceti; Francesca Biagioni; Federica Mastroiacovo; Domenico Bucci; Paola Lenzi; Livia Pasquali; Angela Trabucco; Ferdinando Nicoletti; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2008-08-29       Impact factor: 3.575

6.  Distribution of tyrosine hydroxylase-expressing interneurons with respect to anatomical organization of the neostriatum.

Authors:  Bengi Unal; Osvaldo Ibáñez-Sandoval; Fulva Shah; Elizabeth D Abercrombie; James M Tepper
Journal:  Front Syst Neurosci       Date:  2011-06-06

Review 7.  Striatal cholinergic interneuron regulation and circuit effects.

Authors:  Sean Austin O Lim; Un Jung Kang; Daniel S McGehee
Journal:  Front Synaptic Neurosci       Date:  2014-10-21

8.  Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.

Authors:  Carla DiCaudo; Mario Riverol; Iñaki-Carril Mundiñano; Cristina Ordoñez; María Hernández; Irene Marcilla; Maria-Rosario Luquin
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.